Evidence map›Paper›PMID 33546289›Full record

ArticleInternational journal of molecular sciences2021

κ-Opioid Signaling in the Lateral Hypothalamic Area Modulates Nicotine-Induced Negative Energy Balance.

Patricia Seoane-Collazo, Amparo Romero-Picó, Eva Rial-Pensado, Laura Liñares-Pose, Ánxela Estévez-Salguero, Johan Fernø, Rubén Nogueiras, Carlos Diéguez, Miguel López

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Hypothalamic wars: the last nanodelivery.Reviews in endocrine & metabolic disorders · 2026
    Review
  3. Article
  4. Article
  5. Olfactomedin 2 deficiency protects against diet-induced obesity.Metabolism: clinical and experimental · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Special Issue ofInternational journal of molecular sciences · 2021
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Patricia Seoane-CollazoDepartment of Physiology, CiMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, 15782 Santiago de Compostela, Spain.ORCID 0000-0002-7102-7935
Amparo Romero-PicóDepartment of Physiology, CiMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, 15782 Santiago de Compostela, Spain.ORCID 0000-0001-5104-6998
Eva Rial-PensadoDepartment of Physiology, CiMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, 15782 Santiago de Compostela, Spain.
Laura Liñares-PoseDepartment of Physiology, CiMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, 15782 Santiago de Compostela, Spain.
Ánxela Estévez-SalgueroDepartment of Physiology, CiMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, 15782 Santiago de Compostela, Spain.
Johan FernøHormone Laboratory, Haukeland University Hospital, N-5021 Bergen, Norway.ORCID 0000-0002-4598-2955
Rubén NogueirasDepartment of Physiology, CiMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, 15782 Santiago de Compostela, Spain.ORCID 0000-0002-9976-9930
Carlos DiéguezDepartment of Physiology, CiMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, 15782 Santiago de Compostela, Spain.
Miguel LópezDepartment of Physiology, CiMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, 15782 Santiago de Compostela, Spain.ORCID 0000-0002-7823-1648
Universidade de Santiago de Compostela · ESHaukeland University Hospital · NO

Funding

Atresmedia MLAtresmedia RNEuropean Foundation for the Study of Diabetes RNEuropean Research Council ERC Synergy Grant-2019-WATCH- 810331Fundación BBVA RN"la Caixa" Foundation LCF/PR/HR19/52160016"la Caixa" Foundation LCF/PR/HR19/52160022Ministerio de Economía, Industria y Competitividad, Gobierno de España BFU2017-87721-PMinisterio de Economía, Industria y Competitividad, Gobierno de España RTI2018-099413-B-I00Ministerio de Economía, Industria y Competitividad, Gobierno de España RTI2018-101840-B-I00Xunta de Galicia 2016-2019, ED431G/05Xunta de Galicia 2016-PG057Xunta de Galicia 2016-PG068Xunta de Galicia ED481B 2018/050
6 · The paper itself

Abstract

Several studies have reported that nicotine, the main bioactive component of tobacco, exerts a marked negative energy balance. Apart from its anorectic action, nicotine also modulates energy expenditure, by regulating brown adipose tissue (BAT) thermogenesis and white adipose tissue (WAT) browning. These effects are mainly controlled at the central level by modulation of hypothalamic neuropeptide systems and energy sensors, such as AMP-activated protein kinase (AMPK). In this study, we aimed to investigate the kappa opioid receptor (κOR)/dynorphin signaling in the modulation of nicotine's effects on energy balance. We found that body weight loss after nicotine treatment is associated with a down-regulation of the κOR endogenous ligand dynorphin precursor and with a marked reduction in κOR signaling and the p70 S6 kinase/ribosomal protein S6 (S6K/rpS6) pathway in the lateral hypothalamic area (LHA). The inhibition of these pathways by nicotine was completely blunted in κOR deficient mice, after central pharmacological blockade of κOR, and in rodents where κOR was genetically knocked down specifically in the LHA. Moreover, κOR-mediated nicotine effects on body weight do not depend on orexin. These data unravel a new central regulatory pathway modulating nicotine's effects on energy balance.

Indexed as

Signal TransductionAMP-Activated Protein KinasesAnimalsBody WeightDynorphinsEnergy MetabolismHypothalamic Area, LateralMaleMiceMice, Inbred C57BLNicotineRatsRats, Sprague-DawleyReceptors, Opioid, kappaAMP-Activated Protein KinasesDynorphinsNicotineReceptors, Opioid, kappaAMPKkappa opioid receptorlateral hypothalamusmTORnicotine

Identifiers

PMID33546289
PMCPMC7913331
OpenAlexW3127200335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.